Skip to main content

Results for Chemicals ( 21791 )

    • Ref: T40143
      Sizes: 5 mg, 10 mg

      PROTAC CBP/P300 Degrader-1 (Legacy Tebubio ref. 282T40143). PROTAC CBP/P300 Degrader-1 is an effective compound that potently degrades CBP/P300, significantly reducing cell viability in various cancer cell lines.

      Product detail
    • Ref: T40334
      Sizes: 5 mg
      From: €3,176.00

      PROTAC IRAK3 degrade-1 (Legacy Tebubio ref. 282T40334). PROTAC IRAK3 degrade-1 is a potent and selective degrader of IRAK3 ( IC 50 = 5 nM).

      Product detail
    • Ref: T11291
      Sizes: 5 mg
      From: €1,533.00

      FKBP12 PROTAC dTAG-13 (Legacy Tebubio ref. 282T11291). FKBP12 PROTAC dTAG-13 (dTAG-13) is a heterobifunctional degrader that targets FKBP12F36V with FKBP12F36V expressed in-frame with a protein of interest, and selectively degrades the BET bromodomain transcriptional co-activator BRD4 by bridging BET bromodomains to the E3 ubiquitin ligase CRBN.

      Product detail
    • Ref: T11292
      Sizes: 5 mg
      From: €1,453.00

      FKBP12 PROTAC dTAG-7 (Legacy Tebubio ref. 282T11292). FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional compound that selectively degrades the BET bromodomain transcriptional co-activator BRD4 by linking BET bromodomains to the E3 ubiquitin ligase CRBN. It also functions as a degrader of FKBP12F36V when FKBP12F36V is expressed in-frame with a targeted protein.

      Product detail
    • Ref: T41267
      Sizes: 1 mg, 500 μg
      From: €560.00

      PROTAC(H-PGDS)-7 (Legacy Tebubio ref. 282T41267). PROTAC(H-PGDS)-7 is a selective and potent small molecule hematopoietic prostaglandin D synthase (H-PGDS) PROTAC degradation agent that exhibits degradation activity in KU812 cells with a DC50 of 17.3 pM. It effectively inhibits prostaglandin D2 (PGD2) and is a candidate compound for the treatment of DMD and other H-PGDS-related diseases.

      Product detail
    • Ref: T5437
      Sizes: 5 mg, 25 mg, 100 mg, 50 mg, 10 mg, 2 mg
      From: €44.00

      Gefitinib-based PROTAC 3 (Legacy Tebubio ref. 282T5437). Gefitinib-based PROTAC 3, which connects an EGFR binding element to a VHL ligand via a linker, induces EGFR degradation with DC50s of 11.7 nM and 22.3 nM in HCC827 (exon 19 del) and H3255 (L858R mutation) cells, respectively[1].

      Product detail
    • Ref: T5438
      Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg, 1 mL * 10 mM (in DMSO)
      From: €147.00

      PROTAC CDK9 Degrader-1 (Legacy Tebubio ref. 282T5438). PROTAC CDK9 Degrader-1 is a selective PROTAC CDK9 degrader composed of a cereblon ligand and a CDK9 ligand.

      Product detail
    • Ref: T5835
      Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mg, 200 mg, 1 mL * 10 mM (in DMSO)
      From: €41.00

      PROTAC ERRα ligand 2 (Legacy Tebubio ref. 282T5835). PROTAC ERRα ligand 2 is an inverse agonist for the estrogen-related receptor α (ERRα) with an IC50 of 5.67 nM.

      Product detail
    • Ref: T64284
      Sizes: 25 mg, 100 mg, 50 mg
      From: €1,726.00

      PROTAC CDK12/13 Degrader-1 (Legacy Tebubio ref. 282T64284). PROTAC CDK12/13 Degrader-1 (7f) is a potent and selective dual degrader of the cell cycle protein-dependent kinases CDK12 (DC50: 2.2 nM) and CDK13 (DC50: 2.1 nM), used in the context of breast cancer.

      Product detail